Diabetes Type 1
Metabolic Diseases
1
Pipeline Programs
2
Companies
5
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Eli Lilly and CompanyLY900014
Eli Lilly and CompanyLY900014
Eli Lilly and CompanyLY900014
Eli Lilly and CompanyLY900014
Sanofiinsulin Glargine + Insulin Apidra
Clinical Trials (5)
Total enrollment: 194 patients across 5 trials
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
Start: Feb 2018Est. completion: Sep 201849 patients
Phase 3Completed
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM)
Start: Nov 2017Est. completion: Mar 201836 patients
Phase 1Completed
A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus
Start: Nov 2017Est. completion: Apr 201836 patients
Phase 1Completed
A Study of LY900014 Formulations in Healthy Participants
Start: Jan 2015Est. completion: Sep 201529 patients
Phase 1Completed
Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents
Start: Jul 2009Est. completion: Feb 201244 patients
N/ATerminated
Related Jobs in Metabolic Diseases
Manager, Patient Safety and Pharmacovigilance Operations
Kailera Therapeutics
Waltham, Massachusetts
6h ago
Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV
Amgen
California - San Francisco, US
Yesterday
(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)
Johnson & Johnson
Beerse, Antwerp, Belgium
2d ago
Computational Chemist
Topos Bio
San Francisco Office
2d ago
Associate Director, Legal Operations & Contracts Management
Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr
Diagnostics Value Consultant(Product Marketing) - Diabetes Care Portfolio
Roche
Taipei
5d ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space